Company Description
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies.
It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples.
This segment also creates proprietary 3D culture models used in drug development. The Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal.
The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019.
Predictive Oncology Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania.
| Country | United States |
| Founded | 2002 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 24 |
| CEO | Raymond Vennare |
Contact Details
Address: 91 43rd Street, Suite 110 Pittsburgh, Pennsylvania 15201 United States | |
| Phone | 412 432 1500 |
| Website | predictive-oncology.com |
Stock Details
| Ticker Symbol | POAI |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001446159 |
| CUSIP Number | 74039M200 |
| ISIN Number | US74039M3097 |
| Employer ID | 33-1007393 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Raymond F. Vennare | Chief Executive Officer and Chairman |
| Joshua Blacher CPA, M.B.A. | Interim Chief Financial Officer |
| Dr. Lawrence J. DeLucas D.Sc, O.D, Ph.D. | Senior Vice President of Biologics |
| Dr. Arlette H. Uihlein FCAP, M.D. | Senior Vice President of Translational Medicine and Drug Discovery and Medical Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 18, 2025 | 424B5 | Filing |
| Apr 18, 2025 | 8-K/A | [Amend] Current report |
| Apr 7, 2025 | 8-K | Current Report |
| Apr 1, 2025 | 8-K | Current Report |
| Apr 1, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 31, 2025 | 10-K | Annual Report |
| Mar 20, 2025 | 8-K | Current Report |
| Mar 5, 2025 | 8-K | Current Report |
| Mar 5, 2025 | 425 | Filing |
| Feb 19, 2025 | 8-K | Current Report |